Diaceutics PLC (AIM:DXRX)
132.50
-2.50 (-1.85%)
Jul 20, 2026, 4:35 PM GMT
Diaceutics Revenue
In the year 2025, Diaceutics had annual revenue of 38.44M GBP with 19.53% growth. Diaceutics had revenue of 23.87M in the half year ending December 31, 2025, with 73.31% growth.
Revenue
38.44M
Revenue Growth
+19.53%
P/S Ratio
2.97
Revenue / Employee
187.50K
Employees
205
Market Cap
114.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.44M | 6.28M | 19.53% |
| Dec 31, 2024 | 32.16M | 8.46M | 35.69% |
| Dec 31, 2023 | 23.70M | 4.20M | 21.51% |
| Dec 31, 2022 | 19.50M | 5.56M | 39.88% |
| Dec 31, 2021 | 13.94M | 1.25M | 9.82% |
| Dec 31, 2020 | 12.70M | -746.00K | -5.55% |
| Dec 31, 2019 | 13.44M | 3.07M | 29.58% |
| Dec 31, 2018 | 10.37M | 3.00M | 40.74% |
| Dec 31, 2017 | 7.37M | 2.78M | 60.63% |
| Dec 31, 2016 | 4.59M | 3.19M | 228.33% |
| Dec 31, 2015 | 1.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| INSPECS Group | 191.70M |
| EKF Diagnostics Holdings | 51.56M |
| Venture Life Group | 35.17M |
| Bioventix | 12.54M |
Diaceutics News
- 7 weeks ago - Diaceutics Earnings Call Transcript: H2 2025 - Transcripts
- 7 weeks ago - Diaceutics Annual report: H2 2025 - Filings
- 7 weeks ago - Diaceutics Annual report: H2 2025 - Filings
- 7 weeks ago - Diaceutics Slides: H2 2025 - Filings
- 7 weeks ago - Diaceutics Slides: Corporate presentation - Filings
- 2 months ago - Diaceutics PLC (LSE:DXRX) Q4 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
- 6 months ago - Diaceutics Earnings release: Q4 2025 - Filings
- 10 months ago - Diaceutics Quarterly report: H1 2025 - Filings